Prior Authorization Criteria for GLP-1 and GIP/GLP-1 Receptor Agonists
Customize your policy alerts
Sign up for cvs_caremark Policy 5694-D alerts
Get alerted when Policy 5694-D changes without checking for updates manually.
Monitor payer policy activity
This policy governs prescription coverage and prior authorization for listed GLP-1 receptor agonists and tirzepatide, primarily for type 2 diabetes mellitus, including automated claim screening and clinical review when screening criteria are not met.
No material clinical or coverage changes in this revision.
Coverage Criteria
Type 2 Diabetes Mellitus
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.